Your browser doesn't support javascript.
loading
Measuring Clinical Benefit in Neonatal Randomized Clinical Trials: Challenges and Opportunities.
Massaro, An N; Boyer, Beth; Gill, Mira; Kim, Dure; Laughon, Matthew; Walsh, Michele; Lemmon, Monica E; Pilon, Betsy; Baer, Gerri.
Afiliação
  • Massaro AN; Office of Pediatric Therapeutics, Office of the Commisioner, US FDA, Silver Spring, MD. Electronic address: an.massaro@fda.hhs.gov.
  • Boyer B; Duke-Margolis Center for Health Policy, Washington, DC.
  • Gill M; Duke-Margolis Center for Health Policy, Washington, DC.
  • Kim D; Duke-Margolis Center for Health Policy, Washington, DC.
  • Laughon M; Department of Pediatrics, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Walsh M; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD.
  • Lemmon ME; Duke-Margolis Center for Health Policy, Washington, DC; Departments of Pediatrics and Population Health Sciences, Duke University School of Medicine, Durham, NC.
  • Pilon B; Hope for HIE, West Bloomfield, MI.
  • Baer G; Office of Pediatric Therapeutics, Office of the Commisioner, US FDA, Silver Spring, MD.
J Pediatr ; 269: 113972, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38401783

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos Controlados Aleatórios como Assunto Limite: Humans / Newborn Idioma: En Revista: J Pediatr Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos Controlados Aleatórios como Assunto Limite: Humans / Newborn Idioma: En Revista: J Pediatr Ano de publicação: 2024 Tipo de documento: Article